Clinical trial
ProStat Supplementation in Dialysis Patients
NCT00435123 · Fresenius Medical Care North America, Industry · Terminated
Key facts
| NCT number | NCT00435123 |
|---|---|
| Title | ProStat Supplementation in Dialysis Patients |
| Official title | A Randomized, Placebo Controlled, Double Blind Study of the Use of a Nutritional Supplement, ProStat-64, in Chronic Hemodialysis Patients With Poor Nutritional Status. |
| Lead sponsor | Fresenius Medical Care North America, Industry |
| Collaborators | Medical Nutrition USA, Inc. Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Malnutrition, ESRD |
| Intervention type | Dietary Supplement |
| Interventions | Nutritional Supplement ProStat 64 twice a day, Placebo supplement |
| Enrollment | 16 |
| Start date | Jul 1, 2007 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Feb 14, 2007 |
| Last update posted | Feb 21, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: